Daniel Kwin Grauer, Director at Defence Therapeutics, holds 18.50K shares in Defence Therapeutics (Ticker: DTCFF). Most recently, Daniel Kwin Grauer Bought $8,500 shares of Defence Therapeutics on May 24, 2024 for an estimated value of 10.63K.
What is the percentage of profitable transactions made by Daniel Kwin Grauer?
The percentage of profitable transactions made by Daniel Kwin Grauer is 0%.
What is the average return per transaction made by Daniel Kwin Grauer?
The average return per transaction made by Daniel Kwin Grauer is -58.90%.
What stocks does Daniel Kwin Grauer hold?
Daniel Kwin Grauer holds: DTCFF stocks.
What was Daniel Kwin Grauer’s latest transaction?
Daniel Kwin Grauer latest transaction was an Informative Buy of $10.63K.
What was Daniel Kwin Grauer's most profitable transaction?
Daniel Kwin Grauer’s most profitable transaction was an Informative Buy of DTCFF stock on April 1, 2023. The return on the trade was -45.70%.
What is Daniel Kwin Grauer's role in Defence Therapeutics?
Daniel Kwin Grauer's role in Defence Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.